已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Augmentation of clozapine with electroconvulsive therapy in treatment resistant schizophrenia: A systematic review and meta-analysis

氯氮平 电休克疗法 荟萃分析 医学 精神分裂症(面向对象编程) 不利影响 随机对照试验 内科学 系统回顾 临床试验 梅德林 精神科 儿科 政治学 法学
作者
John Lally,John Tully,Dene Robertson,Brendon Stubbs,Fiona Gaughran,James H. MacCabe
出处
期刊:Schizophrenia Research [Elsevier BV]
卷期号:171 (1-3): 215-224 被引量:124
标识
DOI:10.1016/j.schres.2016.01.024
摘要

The primary aim of this systematic review and meta-analysis was to assess the proportion of patients with Treatment Resistant Schizophrenia (TRS) that respond to ECT augmentation of clozapine (C+ECT). We searched major electronic databases from 1980 to July 2015. We conducted a random effects meta-analysis reporting the proportion of responders to C+ECT in RCTs and open-label trials. Five clinical trials met our eligibility criteria, allowing us to pool data from 71 people with TRS who underwent C+ ECT across 4 open label trials (n=32) and 1 RCT (n=39). The overall pooled proportion of response to C+ECT was 54%, (95% CI: 21.8-83.6%) with some heterogeneity evident (I(2)=69%). With data from retrospective chart reviews, case series and case reports, 192 people treated with C+ECT were included. All studies together demonstrated an overall response to C+ECT of 66% (95% CI: 57.5-74.3%) (83 out of 126 patients responded to C+ECT). The mean number of ECT treatments used to augment clozapine was 11.3. 32% of cases (20 out of 62 patients) with follow up data (range of follow up: 3-468weeks) relapsed following cessation of ECT. Adverse events were reported in 14% of identified cases (24 out of 166 patients). There is a paucity of controlled studies in the literature, with only one single blinded randomised controlled study located, and the predominance of open label trials used in the meta-analysis is a limitation. The data suggests that ECT may be an effective and safe clozapine augmentation strategy in TRS. A higher number of ECT treatments may be required than is standard for other clinical indications. Further research is needed before ECT can be included in standard TRS treatment algorithms.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
迷路翠绿完成签到,获得积分10
1秒前
Xieyusen发布了新的文献求助10
2秒前
5秒前
7秒前
漂亮白枫发布了新的文献求助10
10秒前
Hello应助小药同学采纳,获得10
11秒前
11秒前
12秒前
victoria发布了新的文献求助10
12秒前
王半书发布了新的文献求助10
12秒前
14秒前
小秦秦完成签到 ,获得积分10
14秒前
orixero应助Lulu采纳,获得10
14秒前
哲别发布了新的文献求助10
15秒前
高大的友梅完成签到 ,获得积分10
15秒前
zzzxxxxxyyyyy发布了新的文献求助10
16秒前
doocan完成签到,获得积分10
16秒前
ppg123应助西瓜二郎采纳,获得10
16秒前
momo发布了新的文献求助10
16秒前
隐形曼青应助漂亮白枫采纳,获得10
17秒前
务实觅松完成签到 ,获得积分10
18秒前
coolkid应助负责怀莲采纳,获得10
18秒前
19秒前
YYYZZX1发布了新的文献求助10
19秒前
自由的聋五完成签到,获得积分10
19秒前
木槿花难开完成签到,获得积分10
19秒前
Del完成签到,获得积分10
23秒前
CNX发布了新的文献求助10
24秒前
范范778完成签到 ,获得积分10
24秒前
852应助YYYZZX1采纳,获得10
24秒前
24秒前
不羁完成签到 ,获得积分10
24秒前
25秒前
科研通AI2S应助希特勒采纳,获得10
26秒前
Del发布了新的文献求助10
27秒前
笑笑完成签到 ,获得积分10
27秒前
飞快的老太完成签到,获得积分10
28秒前
29秒前
Hello应助哲别采纳,获得10
29秒前
30秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989832
求助须知:如何正确求助?哪些是违规求助? 3531967
关于积分的说明 11255613
捐赠科研通 3270725
什么是DOI,文献DOI怎么找? 1805035
邀请新用户注册赠送积分活动 882181
科研通“疑难数据库(出版商)”最低求助积分说明 809208